NDC 70677-1087 – Motion Sickness

Dimenhydrinate 50 mg/1 · Tablet · Oral

Human Otc Drug

Product NDC70677-1087

Product details

Brand name
Motion Sickness
Generic name
Dimenhydrinate
Labeler
Strategic Sourcing Services LLC
Dosage form
Tablet
Route
Oral
Marketing category
OTC MONOGRAPH DRUG · M009
Marketed since
May 4, 2023
Listing expires
December 31, 2027
Pharmacologic class
Histamine-1 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Motion Sickness →

Package NDC codes (1)

Package NDCDescriptionSince
70677-1087-12 BLISTER PACK in 1 CARTON (70677-1087-1) / 6 TABLET in 1 BLISTER PACKMay 4, 2023

Other Motion Sickness products